Biotech SF
San Francisco Bay Area biotech stories.
Monday, January 24, 2011
AcelRx Pharmaceuticals prices $81 million IPO
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment